Amplification was observed over cancer genes previously implicated in breast cancer development including ERBB2, CCND1, MYC, MDM2, ZNF217, and ZNF703 and a homozygous deletion involving MAP2K4 was identified. This evidence concerns the gene ZNF217 and breast carcinoma.